Jump to content

Page values for "Brexanolone"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericString
brandStringZulresso
structureFile
classesList of String, delimiter: ,Neuroactive steroid GABA-A positive allosteric modulator
mechanismString
usesStringPostpartum depression (PPD) in adults
starting_doseStringSingle 60-hour continuous IV infusion: 30 mcg/kg/h × 4h → 60 mcg/kg/h × 20h → 90 mcg/kg/h × 28h → 60 mcg/kg/h × 4h → 30 mcg/kg/h × 4h
preparationsString100 mg/20 mL vial, single-use
fda_maxStringSingle 60-hour course
pill_idText
routesList of String, delimiter: ,Intravenous (continuous infusion in a REMS-certified facility)
onsetStringAntidepressant effect within hours of infusion start; sustained at 30 days
durationStringSingle infusion course
halflifeString~9 hours (terminal)
bioavailabilityString100% (IV)
pregnancyStringMedicine is structurally identical to endogenous allopregnanolone; pregnancy considerations relate to breastfeeding during/after infusion. Limited data; brief interruption of breastfeeding considered
legalStringRx; REMS program required (excessive sedation/loss of consciousness during infusion)